Compare ACADIA Pharmaceuticals Inc. (ACAD) vs Credo Technology Group Holding Ltd (CRDO) Price & Performance

ACADIA Pharmaceuticals Inc.Trade

Credo Technology Group Holding LtdTrade

Price performance (Past 24H)

Key statistics

ACADIA Pharmaceuticals Inc. vs Credo Technology Group Holding Ltd — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.84 (market cap $5.07B), while Credo Technology Group Holding Ltd trades at $262 (market cap $46.19B). The key difference: Credo Technology Group Holding Ltd is far larger — about 9.1× ACADIA Pharmaceuticals Inc.'s market cap, and ACADIA Pharmaceuticals Inc. is trading nearer its 52-week high, Credo Technology Group Holding Ltd nearer its low. Which is the better fit depends on your goals.

	ACAD	CRDO
Market Cap	$5.07B	$46.19B
Sector	Health	Technology
52-Week High	$29.41	$302.52
52-Week Low	$20.06	$87.81
Enterprise Value	$4.19B	$44.77B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ACAD

Immunic appoints Elena Ridloff to board ahead of key Phase 3 MS trial data and potential commercialization.PRNewsWire · 1 day agoBullish ACADIA Pharmaceuticals beats Q2 earnings and revenue estimates, raising 2026 revenue forecast and price target.Andrew Wynn · 2 days agoBullish View details →

CRDO

Credo Technology rated Strong Buy on booming AI data center demand and 30%+ annual returns forecast.Seeking Alpha · 7 hours agoBullish Quad 7 Capital advises buying Credo Technology under $200 amid strong AI-driven growth and record fiscal 2026 results.Seeking Alpha · 1 day agoBullish View details →

About ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.

About Credo Technology Group Holding Ltd

Credo Technology provides high-speed connectivity solutions for AI-driven applications and hyperscale data centers. Its products enable faster, more energy-efficient data transmission for cloud and telecom infrastructure.